I. Szinai

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index352citations15works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Biochemical and Molecular Research(7), Pharmacogenetics and Drug Metabolism(2), Folate and B Vitamins Research(2), Cancer, Hypoxia, and Metabolism(2), Analytical Chemistry and Chromatography(2)

Publications15 total

Sustained Retinal Concentrations of OHR3031 Achieved with Intravitreal Injection of a Biodegradable Microparticle Formulation to Rabbits
Investigative Ophthalmology & Visual Science·2016Open Access
Biodegradable Sustained-Release Drug Delivery Systems Fabricated using a Dissolvable Hydrogel Template Technology for the Treatment of Ocular Indications
Investigative Ophthalmology & Visual Science·2015· 8 cited
In-vivo biocompatibility evaluation of stents coated with a new biodegradable elastomeric and functional polymer
Coronary Artery Disease·2002· 73 cited
Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers.
PubMed·1993· 53 cited
<i>cis-trans</i>-Isomerization of [E]-5-(2-bromovinyl)-2,2′-anhydrouridine<i>in vivo</i>in rats
Xenobiotica·1991· 1 cited
Effective sample preparation method for extracting biologically active compounds from different matrices by a microwave technique
Journal of Chromatography A·1990· 118 cited
Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine
Biochemical Pharmacology·1990· 19 cited
Demonstration of stereoselective disposition of warfarin enantiomers by whole-body autoradiography
European Journal of Drug Metabolism and Pharmacokinetics·1990· 3 cited
Biotransformation of 5-(2-chloroethyl)-2'-deoxyuridine in male NMRI mice.
Drug Metabolism and Disposition·1989· 5 cited
Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine.
PubMed·1987· 9 cited
Enzymatic cleavage of 5-substituted-2'-deoxyuridines by pyrimidine nucleoside phosphorylases
Biochemical Pharmacology·1986· 24 cited
Polymeric prodrugs, 3. Synthesis, elimination, and whole‐body distribution of <sup>14</sup>C‐labelled drug carrier
Die Makromolekulare Chemie·1986· 11 cited
5-Substituted-2,2′-anhydrouridines, potent inhibitors of uridine phosphorylase
Biochemical Pharmacology·1985· 28 cited
[1(-trifluoromethyl-(phenyl)-1-phenyl propane-1-ol metabolism in rats].
PubMed·1978
Metabolism of 14C-3-trifluoromethyl-alpha-ethylbenzhydrol in rats.
PubMed·1978

Frequent Co-authors

Anna Szabolcs(4), Géza Dénes(4), László Ötvös(3), Zsuzsa Veres(2), Erik De Clercq(2), Zs. Veres(2), K. UJSZÁSZY(2), Nikita Malavia(2), Laxma G. Reddy(2), А. В. Симонян(2), Robert N. Jennings(2), Glenn Stoller(2), M Ledniczky(2), G Mády(2), S. Holly(2), Kálmán Ujszászi(2), Katalin Ganzler(1), András Salgó(1), Seung Hwan Lee(1), Kenneth M. Carpenter(1)